ALDH9A1 deficiency as a source of endogenous DNA damage that requires repair by the Fanconi anemia pathway Journal Article


Authors: Jung, M. J.; Kim, J.; Park, Y.; Ilyashov, I.; Yang, F.; Choijilsuren, H. B.; Keahi, D.; Durmaz, J. A.; Bea, H.; Goldfarb, A. M.; Stein, M. D.; Wong, C. D.; White, R. R.; Sridhar, S.; Noonan, R.; Wiley, T. F.; Carroll, T. S.; Lach, F. P.; Jeong, S.; Miranda, I. C.; Smogorzewska, A.
Article Title: ALDH9A1 deficiency as a source of endogenous DNA damage that requires repair by the Fanconi anemia pathway
Abstract: The Fanconi anemia (FA) DNA repair pathway is required for the repair of DNA interstrand cross-links (ICLs). ICLs are caused by genotoxins, such as chemotherapeutic agents or reactive aldehydes. Inappropriately repaired ICLs contribute to hematopoietic stem cell (HSC) failure and tumorigenesis. While endogenous acetaldehyde and formaldehyde are known to induce HSC failure and leukemia in FA patients, the effects of other toxic metabolites on FA pathogenesis have not been systematically investigated. Using a metabolism-focused CRISPR screen, we found a synthetically lethal interaction between ALDH9A1 and the deficiency of the FA pathway. Combined deficiency of ALDH9A1 and FANCD2 causes genomic instability, apoptosis, and decreased hematopoietic colony formation. Fanca-/-Aldh9a1-/- mice exhibited an increased incidence of ovarian tumors. A suppressor CRISPR screen revealed that the loss of ATP13A3, a polyamine transporter, resulted in improved survival of FANCD2-/-ALDH9A1-/- cells. These findings nominate high intracellular polyamines and the resulting 3-aminopropanal and acrolein as sources of endogenous DNA damage in patients with FA.
Keywords: aldehydes; formaldehyde; hematopoietic stem; cancer; bone-marrow failure
Journal Title: Journal of Cell Biology
Volume: 224
Issue: 7
ISSN: 0021-9525
Publisher: Rockefeller University Press  
Date Published: 2025-06-01
Start Page: e202407141
Language: English
ACCESSION: WOS:001514503400001
DOI: 10.1083/jcb.202407141
PROVIDER: wos
PMCID: PMC12187107
PUBMED: 40540243
Notes: The MSK Cancer Center Support Grant (P30 CA008748) is acknowledge in the PDF -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Ileana C. Miranda
    16 Miranda